interleukin 1-beta inhibitors (Cedars Sinai)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameinterleukin 1-beta inhibitors (Cedars Sinai)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-1 beta inhibitors
TargetsInterleukin-1 beta
Therapy Area/IndicationsRespiratory Distress Syndrome, Adult
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCedars-Sinai Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCedars-Sinai Medical Center
Active IndicationsN/A
Inactive IndicationsRespiratory Distress Syndrome, Adult

Other Information

ATC CodeN/A
Related LinksN/A